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BACKGROUND: Brain-derived neurotrophic factor (BDNF) is suggested to play a key role in 17 
moderating the benefits of physical activity (PA) on cognition. Previous research found that PA 18 
may have an impact on peripheral BDNF expression. The aim of our study was to analyse the 19 
association between objectively measured PA with circulating BDNF in a group of active 20 
adolescents. METHODS: 234 adolescents (132 boys) aged 13.9±0.3 years old from the DADOS 21 
study were included in this cross-sectional analysis. PA was assessed by GENEActiv triaxial 22 
accelerometer. Participants wore the accelerometer on their non-dominant wrist for 6 consecutive 23 
24-h days, including weekends. PA was expressed as the average (min/day) of light, moderate and 24 
vigorous PA. Fasting plasma BDNF concentrations at rest were measured using an enzyme-linked 25 
immunosorbent assay. Partial correlations and linear regression analyses were performed with a 26 
significance level established at p<0.05. RESULTS: No correlations were found between BDNF 27 
and PA variables. Plasma levels of BDNF at rest were not significantly associated with daily PA in 28 
either boys or girls (p>0.05). CONCLUSION: Based on previous research and our own data, the 29 
association between daily PA and baseline levels of BDNF remains inconclusive. Further research 30 
is needed to shed light on the relationship between regular PA and BDNF in adolescents.  31 
 32 
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The importance of maintaining an active lifestyle during youth is well accepted nowadays, not 36 
only for its benefits on physical health but also for its influence on cognition (Hillman et al. 2015). 37 
Prior research indicates that regular physical activity (PA) induces several physiological adaptations 38 
like enhanced brain function and increased vascularization, which may translate into cognitive 39 
benefits (Lubans et al. 2016). Evidence from animal and human studies suggests that brain-derived 40 
neurotrophic factor (BDNF) could be a key molecule behind those physiological adaptations 41 
(Phillips, Baktir, Srivatsan, & Salehi, 2014). 42 
BDNF is a protein member of the nerve growth factors family which in humans is mostly 43 
expressed in the central nervous system, but it is also produced peripherally (i.e. skeletal muscle, 44 
adipose tissue) (Noble et al. 2011). Although BDNF cannot be measured centrally in humans, 45 
central BDNF can cross the blood-brain barrier bi-directionally (Pan et al. 1998); thus, it is 46 
suggested that peripheral levels of BDNF may have central effects (Serra-Millàs 2016). BDNF has 47 
been found to play an important role in various aspects of brain development like neuronal survival, 48 
regeneration and proliferation, as well as synapse formation and plasticity, which may translate into 49 
better cognitive functions (Park and Poo 2013). Indeed, higher BDNF levels have been related to 50 
improved cognitive processes like memory (Whiteman et al. 2014) as well as improved cortical 51 
brain development (Herting et al. 2016).  52 
BDNF concentrations have been found to increase peripherally, both in plasma and serum, after 53 
acute and chronic aerobic exercise in healthy adults (Huang, Larsen, Ried-Larsen, Møller, & 54 
Andersen, 2014). These findings have supported the idea that exercise could be viewed as a 55 
potential strategy for inducing BDNF secretion. Despite some knowledge has been acquired from 56 
studies in adult population, the association between circulating BDNF at rest with long-term effects 57 
of PA has been poorly investigated in healthy youth (Pareja-Galeano et al. 2013; Lee et al. 2014; 58 
Kim 2016; Huang et al. 2017; Jeon and Ha 2017). In addition, results are contradictory in this age-59 
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span since both direct (Jeon & Ha, 2015, 2017; Pareja-Galeano et al., 2013) and inverse 60 
relationships have been reported (Lee et al. 2014; Kim 2016; Huang et al. 2017).   61 
Adolescence is a period of significant neurodevelopment (Hueston et al. 2017) characterized by 62 
the establishment of many health-related behaviours (Sawyer et al. 2012). Thus, investigating 63 
factors related to neurogenesis in this age-span is particularly consequential. Given the suggested 64 
benefits of BDNF on cognition, it is of interest to elucidate if daily PA is associated with circulating 65 
BDNF levels at rest in adolescents. Thus, the aim of our study was to analyse the association 66 
between objectively measured PA with circulating BDNF in a group of physically active 67 
adolescents.  68 
MATERIAL AND METHODS 69 
Study design and participants 70 
The present study is part of the DADOS (Deporte, ADOlescencia y Salud) study which has been 71 
described previously (Beltran-Valls et al. 2017). Briefly, it is a 3-year longitudinal research project 72 
aimed to investigate the influence of PA on health and development in adolescents. All participants 73 
were volunteers recruited from secondary schools and sports clubs of Castellon (Spain), and met the 74 
general DADOS inclusion criteria: born in 2001, enrolled in the 2nd grade of secondary school, and 75 
free of any chronic disease. The results presented in this cross-sectional analysis belong to baseline 76 
data obtained between February and May of 2015. A total of 234 adolescents (132 boys) with valid 77 
data for BDNF, body mass index (BMI), pubertal status and achieving 60 min/day of Moderate and 78 
Vigorous PA (MVPA) as proposed by the World Health Organization (WHO. 2010), were included 79 
in the analysis. Adolescents and their parents or guardians were informed of the nature and 80 
characteristics of the study, and all provided a written informed consent. The study was performed 81 
following the ethical guidelines of the Declaration of Helsinki 1961 (revision of Fortaleza 2013), 82 




Physical Activity Measurement 85 
PA levels were objectively measured using the GENEActiv accelerometer (Activinsights Ltd, 86 
Kimbolton, UK), a waterproof device which contains a triaxial microelectromechanical-87 
accelerometer that records both motion-related and gravitational acceleration and has a linear and 88 
equal sensitivity along the three axes. Participants wore the accelerometer on their non-dominant 89 
wrist for 6 consecutive 24-h days, including weekend and week days. GENEActiv accelerometer 90 
has been found to be a reliable (Coefficient of Variation intra-instrument = 1.4%, Coefficient of 91 
Variation inter-instrument = 2.1%) (Esliger et al. 2011) and valid objective measure of PA in young 92 
people (r = 0.925, P = 0.001) (Phillips, Parfitt, & Rowlands, 2013). Devices were programmed with 93 
a sampling frequency of 100 Hz, and data were stored in gravity (g) units (1 g = 9.81 m/s²). The raw 94 
acceleration output was converted to 1 second epochs using the GENEActiv Post-Processing PC 95 
Software (version 2.2, GENEActiv). By combining all registered days for each participant and 96 
according to Phillips et al. (2013), PA was expressed as the average (min/day) of light, moderate, 97 
vigorous and moderate plus vigorous PA. Total PA was calculated by adding all PA intensities. 98 
Plasma BDNF concentrations 99 
After an overnight fast, blood samples (~20ml) were drawn from the antecubital vein while 100 
subjects remained in seated position in our laboratory (between 8:00-9:00 am). Blood samples in 101 
EDTA tubes (Greiner bio-one, Kremsmünster, Austria) were used for plasma collection by 102 
centrifugation of blood at 3500 rpm×10 min at 4ºC. Plasma samples were aliquoted and stored at 103 
−80 °C until analysis. Plasma BDNF concentration was measured using a commercially available 104 
sensitive ELISA kit for BDNF (EIA-4147 BDNF Enzyme-Linked Immunosorbent Assay; DRG 105 
Instruments GmbH, Marburg, Germany), according to manufacturer’s instructions. The sensitivity 106 





Due to the influence of age, sex, pubertal status, BMI, sport participation and weekly training 110 
sessions on circulating BDNF levels, these factors were included in the analyses as confounders 111 
(Lommatzsch et al. 2005; Iughetti et al. 2011).  112 
Pubertal status was self-reported according to the 5 stages described by Tanner and Whitehouse 113 
(Tanner and Whitehouse 1976). It is based on external primary and secondary sex characteristics, 114 
which are described by the participants using standard pictures according to Tanner instructions.  115 
Body mass index (BMI) was calculated as weight/height square (kg/m2). Body weight was 116 
measured to the nearest 0.1 kg using an electronic scale (SECA 861, Hamburg, Germany). Height 117 
was measured to the nearest 0.1 cm using a wall-mounted stadiometer (SECA 213, Hamburg, 118 
Germany). Measures were assessed in duplicate and average measures were used for the analyses. 119 
The adolescents reported their participation in organized sports and number of training sessions 120 
per week by answering the following questions: For how many years have you participated in 121 
organized sports? and how many training sessions do you complete during a standard week? 122 
Organized sport was defined as sport activities guided by a coach and having regular competitions. 123 
Participants reported the number of years training and it was included in the data analyses as a 124 
continuous variable. The options for number of training sessions were: “5 or more per week”, “4 per 125 
week”, “3 per week”, “2 per week”, and “once per week”. 126 
Statistical analysis 127 
To achieve normality, values of BMI, PA and BDNF levels were log transformed before 128 
analyses. Descriptive sample characteristics were summarized by sex and were presented as mean ± 129 
standard deviation (SD). Differences between boys and girls were examined using independent t-130 
test. Partial correlation analysis controlling for age, sex, pubertal status, BMI, sport participation 131 




Linear regression models were implemented to analyse the associations between PA and BDNF, 134 
controlling for age, pubertal status, BMI, sport participation and weekly training sessions. Even 135 
though we did not observe a significant interaction effect for sex and BDNF, analyses were 136 
performed separately for boys and girls due to the reported impact of sex on BDNF circulating 137 
levels (Lommatzsch et al. 2005) and the differences in PA levels found between sexes. All the 138 
analyses were performed using the IBM SPSS Statistics for Windows version 22.0 (Armonk, NY: 139 
IBM Corp). The level of significance was set at p<0.05. 140 
RESULTS 141 
Table 1 shows descriptive characteristics of the study sample by sex. Boys were taller and more 142 
physically active than girls (p<0.001). No differences between sexes were found for age, BMI or 143 
BDNF levels. 144 
**Table 1 around here** 145 
Partial correlations did not reveal any significant association between PA and BDNF levels after 146 
controlling for age, sex, pubertal status, BMI, sport participation and weekly training sessions (table 147 
2). 148 
**Table 2 around here** 149 
Table 3 shows the association between PA variables and BDNF levels for boys and girls. Neither 150 
the total daily PA nor the specific PA intensities showed a significant association with resting 151 
plasma BDNF levels in boys or girls (p>0.05). Linear regression analyses performed on the whole 152 
sample (including boys and girls) did not show either any significant association between PA 153 
variables and BDNF levels (p>0.05, data not shown). 154 




The main finding of this cross-sectional study showed that, after controlling for potential 157 
confounders, objectively measured PA levels were not associated with resting plasma BDNF in a 158 
sample of adolescents meeting daily PA recommendations (≥60min/day MVPA). The present study 159 
expands the scarce current literature analysing the association between PA and BDNF in healthy 160 
and physically active adolescents. 161 
Previous intervention research analysing the effect of aerobic exercise on BDNF levels in 162 
adolescents showed contradictory results since several studies identified an increase in BDNF levels 163 
(Jeon & Ha, 2015, 2017; Pareja-Galeano et al., 2013), while others reported a decrease (Lee et al. 164 
2014; Kim 2016). Similarly to our study, Huang et al. (2017) analysed the association between 165 
BDNF and PA in a sample of 415 adolescents and found a negative association of BDNF levels 166 
with MVPA only in boys. The lack of association between BDNF and PA identified in our sample 167 
of healthy adolescents could be partially explained by the fact that all the participants in the study 168 
were physically active adolescents (≥ 60 min/day MVPA). In addition, the discrepancy between our 169 
results and previous research could be related to the fact that they investigated the association 170 
between BDNF and PA in serum (Lee et al. 2014; Jeon and Ha 2015, 2017; Kim 2016). 171 
The association between BDNF and different levels of PA has been analysed only by Jeon & Ha 172 
(2017) in an intervention study performing 12 weeks of aerobic exercise with a small sample of 40 173 
male adolescents. They found that the group performing high intensity exercise increased 174 
significantly the BDNF levels at rest compared to the low intensity exercise and the control groups. 175 
Despite the different design of the study, our results revealed no association between BDNF and 176 
any PA levels. Again, the specific characteristics of our sample and the methodological differences 177 
among both studies could partially explain the lack of agreement between the findings.  178 
All in all, we believe that methodological issues could be behind the controversial results found 179 
in the recent scientific literature. Firstly, different results could be related to the matrix (serum 180 
versus plasma) in which BDNF is measured in the studies. Since BDNF is stored and released by 181 
platelets (Fujimura et al. 2002), it is possible that factors affecting platelets functioning like exercise 182 
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(El-Sayed et al. 2005), clotting time or temperature of serum collection (Pareja-Galeano et al. 2015) 183 
might influence the concentration of BDNF in serum. Therefore, BDNF levels from plasma and 184 
serum in different studies might not be directly comparable (Serra-Millàs 2016). Secondly, 185 
analysing BDNF with ELISA kits does not allow to differentiate between the two forms of BDNF: 186 
mature BDNF and pro-BDNF which both can be found in circulation and are thought to exert 187 
distinct and opposed functions (Serra-Millàs 2016), as well as to respond differently to PA (Brunelli 188 
et al. 2012). Therefore, our and other studies showing results obtained from ELISA procedure did 189 
not account for differential levels of those two circulating molecules of BDNF in the population 190 
investigated. Finally, genetic factors might play a role in the association analysed. A single 191 
nucleotide polymorphism within the BDNF gene, known as the val66met, has been identified and 192 
related to BDNF secretion and functioning alterations (Egan et al. 2003). Indeed, individuals 193 
carrying the polymorphisms have shown decreased activity-dependent secretion of BDNF as 194 
compared to the not carriers (Egan et al. 2003). Moreover, it has recently been suggested that 195 
BDNF genotype may moderate the relationship between aerobic fitness and cortical structure in 196 
adolescents (Herting et al. 2016) and the benefits of exercise on cognition in young adults (Hopkins 197 
et al. 2012). Thus, the comparison between results of different studies might be hampered by 198 
genetic features if this issue is not considered in the population investigated.   199 
The present study has some strengths including the objective assessment of different levels of 200 
daily PA with an accelerometer that can be worn continuously for 24h, as well as the relatively 201 
large and homogeneous sample in terms of age. In addition, the statistical analyses were controlled 202 
for age, pubertal status, BMI, sport participation and weekly training sessions. However, the cross-203 
sectional design of the study limits our ability to make assumptions about the causal nature of the 204 
analysed association. 205 
In conclusion, we found no association between circulating resting levels of plasma BDNF and 206 
different levels of objectively assessed daily PA in healthy and physically active adolescents. Given 207 
the inconclusive results in the current scientific literature, further research which considers the 208 
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methodological issues raised is needed to shed light on the relationship between BDNF and PA 209 
during adolescence. Increasing the knowledge of behaviours which influence this neuroplasticity-210 
related protein might help understanding determinants of cognitive performance.  211 
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  300 
Table 1. Characteristics of the study sample by sex (n=234). 
Variable All (n=234) Boys (n=132) Girls (n=102) p 
Demographics 
Age (y) a 13.9 ± 0.3 13.9 ± 0.3 13.9 ± 0.3 0.71 
Tanner stages b 
   Stage 2 
   Stage 3 
   Stage 4 


















Height (cm)  163.1 ± 8.0 164.7 ± 8.5 160.9 ± 6.6 0.00 
Weight (kg)  54.0 ± 8.8 54.3 ± 8.9 53.6 ± 8.8 0.25 
BMI (kg/m2)  20.2 ± 2.6 19.9 ± 2.2 20.6 ± 2.9 0.07 
PA (min/day) a 
Total PA  275.0 ± 74.2 277.2 ± 73.6 272.0 ± 75.1 0.23 
Light PA  179.5 ± 58.0 176.8 ± 59.0 183.1 ± 56.7 0.21 
Moderate PA  81.4 ± 24.3 84.2 ± 23.7 77.9 ± 24.8 0.00 
Vigorous PA  14.0 ± 8.1 16.3 ± 7.5 10.9 ± 7.8 0.00 
MVPA  95.4 ± 28.3 100.5 ± 27.2 88.9 ± 28.4 0.00 
BDNF (pg/ml) a 251.8 ± 113.5 254.1 ± 111.7 248.9 ± 116.1 0.69 
Data are presented as a mean ± standard deviation, b frequency (%). Differences between sexes were 
examined by independent t-test.  
BMI: body mass index; PA: physical activity; MVPA: moderate and vigorous physical activity; BDNF: 
Brain-derived neurotrophic factor. 
15 
 
Table 2. Partial correlation between BDNF and PA variables (n=234). 
 Total PA Light PA Moderate PA Vigorous PA MVPA 
BDNF -0.02 -0.01 -0.06 0.05 -0.04 
Total PA  0.95 0.75 0.28 0.73 
Light PA   0.50 0.10 0.47 
Moderate PA    0.34 0.97 
Vigorous PA     0.55 
Data are presented in the correlation coefficient R. Values in bold indicate significant results with 
p<0.001. Analyses controlled for age, sex, pubertal status, BMI, sport participation and frequency 
of training. 
PA: physical activity; MVPA: moderate and vigorous physical activity; BDNF: Brain-derived 
neurotrophic factor 
 301 




Table 3. Linear regression analyses between PA and BDNF. 
 Boys (n=132) Girls (n=102) 
 β 95% CI P Β 95% CI P 
Total PA -0.05 -0.54; 0.28 0.53 0.07 -0.30; 0.68 0.44 
Light PA -0.06 -0.53; 0.26 0.49 0.06 -0.32; 0.63 0.52 
Moderate PA -0.04 -0.40; 0.25 0.64 0.15 -0.36; 0.41 0.88 
Vigorous PA 0.07 -0.11; 0.23 0.48 0.15 -0.06; 0.25 0.24 
MVPA -0.03 -0.37; 0.27 0.76 0.06 -0.28; 0.49 0.59 
Data are presented as standardized β and 95% CI. Analyses were adjusted for age, pubertal status, BMI, 
sport participation and frequency of training. 
PA: physical activity; MVPA: moderate and vigorous physical activity; BDNF: Brain-derived 
neurotrophic factor; CI: confidence intervals. 
 304 
